ETIOPATHOGENETIC FEATURES OF NEONATAL SEPSIS: CONTEMPORARY EVIDENCE ON MICROBIAL ETIOLOGY, HOST RESPONSE, AND DIAGNOSTIC STRATEGIES

Authors

Keywords:

neonatal sepsis; early-onset sepsis; late-onset sepsis; Gram-negative bacteria; innate immunity; antimicrobial resistance; blood culture; inflammatory biomarkers.

Abstract

Neonatal sepsis remains a major cause of preventable morbidity and mortality, particularly among preterm and very-low-birth-weight infants. This narrative review critically examines contemporary microbial epidemiology, the immature neonatal immune response, endothelial and microcirculatory injury, diagnostic uncertainty, and antimicrobial resistance. Selected systematic reviews and international guidance were synthesized without an exhaustive systematic search or original patient-level analysis. A population-based meta-analysis estimated 28.24 neonatal sepsis cases per 1,000 live births (95% confidence interval [CI] 18.92–41.94), with substantial between-study heterogeneity. A more recent pathogen meta-analysis reported that Gram-negative organisms represented 53% of early-onset and 71% of late-onset isolates in the analyzed samples, challenging overly rigid pathogen assumptions based on timing alone. Blood culture remains essential but is limited by sampling volume and previous antibiotic exposure; inflammatory biomarkers require serial, context-sensitive interpretation. An integrated approach combining clinical surveillance, microbiological evidence, antimicrobial stewardship, and infection prevention is therefore essential. These figures describe published cohorts and must not be interpreted as locally measured data.

References

1.Fleischmann C, et al. Global incidence and mortality of neonatal sepsis: a systematic review and meta-analysis. Arch Dis Child. 2021. doi:10.1136/archdischild-2020-320217.

2.Shane AL, Sánchez PJ, Stoll BJ. Neonatal sepsis. Lancet. 2017;390:1770–1780. doi:10.1016/S0140-6736(17)31002-4.

3.Wynn JL. Defining neonatal sepsis. Curr Opin Pediatr. 2016;28:135–140. doi:10.1097/MOP.0000000000000315.

4.Camacho-Gonzalez A, Spearman PW, Stoll BJ. Neonatal infectious diseases: evaluation of neonatal sepsis. Pediatr Clin North Am. 2013;60:367–389. doi:10.1016/j.pcl.2012.12.003.

5.Harrison ML, Dickson BFR, Sharland M, Williams PCM. Beyond early- and late-onset neonatal sepsis definitions: what are the current causes of neonatal sepsis globally? Pediatr Infect Dis J. 2024;43:1182–1190. doi:10.1097/INF.0000000000004485.

6.National Institute for Health and Care Excellence. Neonatal infection: antibiotics for prevention and treatment. NICE guideline NG195. 2021; updated 2024. https://www.nice.org.uk/guidance/ng195

7.Polin RA; Committee on Fetus and Newborn. Management of neonates with suspected or proven early-onset bacterial sepsis. Pediatrics. 2012;129:1006–1015. doi:10.1542/peds.2012-0541.

8.Simonsen KA, Anderson-Berry AL, Delair SF, Davies HD. Early-onset neonatal sepsis. Clin Microbiol Rev. 2014;27:21–47. doi:10.1128/CMR.00031-13.

9.Wynn JL, Wong HR. Pathophysiology and treatment of septic shock in neonates. Clin Perinatol. 2010;37:439–479. doi:10.1016/j.clp.2010.04.002.

10.Schlapbach LJ, et al. Mortality related to invasive infections, sepsis, and septic shock in critically ill neonates and children. JAMA Pediatr. 2015;169:46–54. doi:10.1001/jamapediatrics.2014.1616.

11.Singer M, et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA. 2016;315:801–810. doi:10.1001/jama.2016.0287. (Adult consensus; neonatal application requires caution.)

12.World Health Organization. WHO recommendations for management of serious bacterial infections in infants aged 0–59 days. Geneva: WHO; 2024. ISBN 9789240102903.

13.Fleischmann-Struzek C, et al. The global burden of paediatric and neonatal sepsis: a systematic review. Lancet Respir Med. 2018;6:223–230. doi:10.1016/S2213-2600(18)30063-8.

14.Dong Y, Speer CP. Late-onset neonatal sepsis: recent developments. Arch Dis Child Fetal Neonatal Ed. 2015;100:F257–F263. doi:10.1136/archdischild-2014-306213.

15.Okomo U, et al. Aetiology of invasive bacterial infection and antimicrobial resistance in neonates in sub-Saharan Africa: a systematic review and meta-analysis in line with the STROBE-NI reporting guidelines. Lancet Infect Dis. 2019;19:1219–1234. doi:10.1016/S1473-3099(19)30414-1.

Published

2026-10-15